The ability of serum adiponectin levels to predict the progression of acute coronary syndrome (ACS) (conditions causing a sudden decrease in blood flow) was studied, and it was concluded that increased cardiovascular events in male patients aged ≥65 years, with BMI <25 kg/m2, were linked to an increase in adiponectin levels. Here, ADIPOQ is linked to acute coronary syndrome.